Listed

Dolby Laboratories, Inc.

DLBNYSECIK 1308547FinancialsFiscal year ends Sep 27

Reports and events: 291 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Dolby Laboratories, Inc., Reports and events
FiledFormWhat it isAccession number
2026-08-2709:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-369707
2026-07-3016:37 ET10-QQuarterly reportPeriod 2026-06-260001308547-26-000013
2026-07-3016:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-326149
2026-04-3016:45 ET10-QQuarterly reportPeriod 2026-03-270001308547-26-000010
2026-04-3016:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-197338
2026-02-1317:33 ETSCHEDULE 13D/AOwnership report, active investor, amended0001193125-26-051828
2026-02-0616:15 ET8-K5.07 Shareholder vote results0001193125-26-041211
2026-01-2916:57 ET10-QQuarterly reportPeriod 2025-12-260001308547-26-000005
2026-01-2916:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-029373
2025-12-1608:30 ETDEF 14AProxy statementPeriod 2026-02-030001193125-25-320032
2025-11-1817:01 ET10-KAnnual reportPeriod 2025-09-260001308547-25-000007
2025-11-1816:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-286178
2025-11-1416:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-25-283128
2025-07-3116:58 ET10-QQuarterly reportPeriod 2025-06-270001628280-25-037059
2025-07-3116:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-170537
2025-05-0116:52 ET10-QQuarterly reportPeriod 2025-03-280001628280-25-021591
2025-05-0116:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-109982
2025-02-0716:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-25-022734
2025-02-0316:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-012351
2025-01-3016:06 ET10-QQuarterly reportPeriod 2024-12-270001628280-25-003175
2025-01-2916:19 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-015678
2024-12-2008:46 ETDEF 14AProxy statementPeriod 2025-02-040001193125-24-282542
2024-11-1917:07 ET10-KAnnual reportPeriod 2024-09-270001628280-24-048519
2024-11-1916:19 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-261743
2024-11-1516:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-259854
2024-08-1917:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-202859
2024-08-0717:11 ET10-QQuarterly reportPeriod 2024-06-280001628280-24-035707
2024-08-0716:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-195903
2024-06-0608:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-155603
2024-05-0217:02 ET10-QQuarterly reportPeriod 2024-03-290001628280-24-020061
2024-05-0216:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-129380
2024-02-0916:19 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-030031
2024-02-0217:48 ET10-QQuarterly reportPeriod 2023-12-290001628280-24-002964
2024-02-0116:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-021860
2023-12-2208:35 ETDEF 14AProxy statementPeriod 2024-02-060001193125-23-301817
2023-11-1721:33 ET10-KAnnual reportPeriod 2023-09-290001628280-23-039389
2023-11-1616:17 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-278816
2023-08-0317:26 ET10-QQuarterly reportPeriod 2023-06-300001628280-23-027347
2023-08-0316:16 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-23-004979
2023-05-0518:00 ET10-QQuarterly reportPeriod 2023-03-310001628280-23-015875
2023-05-0416:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-23-002894
2023-02-1016:18 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-032624
2023-02-0217:01 ET10-QQuarterly reportPeriod 2022-12-300001628280-23-002065
2023-02-0216:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-23-000636
2022-12-1908:30 ETDEF 14AProxy statementPeriod 2023-02-070001193125-22-307928
2022-11-1816:46 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-289071
2022-11-1816:07 ETSC 13D/AOwnership report, active investor, amended0001193125-22-288960
2022-11-1821:31 ET10-KAnnual reportPeriod 2022-09-300001628280-22-030390
2022-11-1716:15 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-22-007571
2022-08-0916:37 ET10-QQuarterly reportPeriod 2022-07-010001628280-22-021971

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 09:52 ET. Listed shows no prices and gives no investment advice.